Table 2.

Postoperative complications and mortality

	Patients with COPD (n=130)
	LAMA/LABA	LAMA	p value*	No-BD	p value**
	n=64	n=23		n=43
Complications
Any	14 (21.9)	12 (52.2)	0.007	16 (37.2)	0.083
Pneumonia	7 (10.9)	6 (26.1)	0.081	7 (16.3)	0.422
Acute respiratory failure	1 (1.6)	2 (8.7)	0.124	2 (4.7)	0.342
Prolonged air leakage	6 (9.4)	5 (21.7)	0.126	11 (25.6)	0.012
Atrial fibrillation	4 (6.3)	2 (8.7)	0.776	4 (9.3)	0.557
Introduction of HOT	3 (4.7)	3 (13.0)	0.008	0	0.176
30-day mortality	0	0		0
90-day mortality	0	1 (4.3)	0.093	1 (2.3)	0.246

Data are presented as n (%)

COPD chronic obstructive pulmonary disease; LAMA long-acting muscarinic antagonists; LABA long-acting 2-agonists; BD bronchodilator; HOT home oxygen therapy

^*Significance of LAMA/LABA versus LAMA

^**Significance of LAMA/LABA versus No-BD